EUVIMEDEUVIMED entdecken
Crossref

Critical considerations of mRNA–LNP technology for CAR-T therapy: components, payloads and emerging horizons

YunFeng Qu, Renfa Liu, Desheng Sun, Zhifei Dai

Materials Chemistry Frontiers · 2024 · 8 (19) · 3106-3135

DOI: 10.1039/d4qm00479e ↗

Kurz gefasst

Fachartikel in der Zeitschrift Materials Chemistry Frontiers, 2024. Verfasst von YunFeng Qu und 3 weiteren Autor:innen. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 241 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sanming Project of Medicine in Shenzen Municipality.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The application and optimization of circRNA-LNP.

Förderung

  • National Natural Science Foundation of China
  • Sanming Project of Medicine in Shenzen Municipality

Zitieren

APA

Qu, Y., Liu, R., Sun, D., & Dai, Z. (2024). Critical considerations of mRNA–LNP technology for CAR-T therapy: components, payloads and emerging horizons. Materials Chemistry Frontiers, 8(19), 3106-3135. https://doi.org/10.1039/d4qm00479e

Vancouver

Qu Y, Liu R, Sun D, Dai Z. Critical considerations of mRNA–LNP technology for CAR-T therapy: components, payloads and emerging horizons. Materials Chemistry Frontiers. 2024;8(19):3106-3135. doi:10.1039/d4qm00479e

BibTeX
@article{Qu2024,
  author = {Qu, YunFeng and Liu, Renfa and Sun, Desheng and Dai, Zhifei},
  title = {Critical considerations of mRNA–LNP technology for CAR-T therapy: components, payloads and emerging horizons},
  journal = {Materials Chemistry Frontiers},
  year = {2024},
  volume = {8},
  number = {19},
  pages = {3106--3135},
  doi = {10.1039/d4qm00479e}
}
Kostenlos starten →